Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens-Reference-Cited by-同舟云学术

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens

Published:2016-03-16 Issue:4 Volume:21 Page:393-398
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Siva Shankar¹²,Ball David¹²

Affiliation:

1. a Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

2. b Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia

Abstract

In 2016, surgery is the standard of care for peripheral stage I non-small cell lung cancer. However, recent thought-provoking randomized evidence suggests stereotactic ablative body radiotherapy (SABR) has survival outcomes similar to those of surgery. Albeit limited, patient-reported outcomes and quality of life suggest that SABR compares favorably to surgery because it is noninvasive and associated with relatively few treatment-related complications. This article explores the current scientific landscape of surgery and SABR in this patient cohort.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2015-0477

Reference37 articles.

1. The treatment of carcinoma of the bronchus: A clinical trial to compare surgery and supervoltage radiotherapy;Morrison;Lancet,1963

2. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer;Ginsberg;Ann Thorac Surg,1995

3. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial;Albain;Lancet,2009

4. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer;Van Meerbeeck;J Natl Cancer Inst,2007

5. The 30- versus 90-day operative mortality after pulmonary resection;Bryant;Ann Thorac Surg,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchoscopic Thermal Vapour Ablation for Localized Cancer Lesions of the Lung: A Clinical Feasibility Treat-and-Resect Study;Respiration;2021

2. Bronchoscopic treatments for early‐stage peripheral lung cancer: Are we ready for prime time?;Respirology;2020-07-08

3. A reply to “A comment on “Lung cancer surgical treatment after solid organ transplantation: a single center 30-year experience”;Lung Cancer;2020-07

4. Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial;The Oncologist;2020-03-25

5. Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors;Scientific Reports;2019-10-29